Cooperative activation of human TLR9 and consequences for the clinical development of antisense and CpG oligodeoxynucleotides

被引：1
|
作者：
Hartmann, Gunther [1 ]
机构：
[1] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Campus Venusberg, Bonn, Germany
来源：
MOLECULAR THERAPY NUCLEIC ACIDS | 2023年 / 34卷
关键词：
B-CELL ACTIVATION;
D O I：
10.1016/j.omtn.2023.102078
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] TLR9的特性及其介导的TLR9/CpG-DNA免疫信号通路
    桑丽敏
    唐立
    中国微生态学杂志, 2010, 22 (12) : 1143 - 1146+1149
  • [32] Human pharmacologic activity of a new TLR9 agonist antiviral, CPG 10101 (Actilon™)
    McHutchison, JG
    Bacon, BR
    Gordon, SC
    Afdhal, NH
    Jacobson, IM
    Muir, A
    Krieg, AM
    Efler, S
    Al-Adhami, M
    Davis, HL
    Schmalbach, TK
    HEPATOLOGY, 2004, 40 (04) : 697A - 697A
  • [33] Comparison of human B cell activation by TLR7 and TLR9 agonists
    Hanten, John A.
    Vasilakos, John P.
    Riter, Christie L.
    Neys, Lori
    Lipson, Kenneth E.
    Alkan, Sefik S.
    Birmachu, Woubalem
    BMC IMMUNOLOGY, 2008, 9 (1)
  • [34] Comparison of human B cell activation by TLR7 and TLR9 agonists
    John A Hanten
    John P Vasilakos
    Christie L Riter
    Lori Neys
    Kenneth E Lipson
    Sefik S Alkan
    Woubalem Birmachu
    BMC Immunology, 9
  • [35] CpG Ofigodeoxynudeofides as TLR9 Agonists Therapeutic Applications in Cancer
    Murad, Yanal M.
    Clay, Timothy M.
    BIODRUGS, 2009, 23 (06) : 361 - 375
  • [36] The TLR9 agonist CpG ODN attenuates cardiac hypertrophy
    Yang, L.
    Jiao, J.
    Zhang, J.
    Li, J.
    Tang, X.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (06) : 1011 - 1011
  • [37] Synergistic intracellular sensing by NOD2 and TLR9 enables activation of human monocytes by CpG-DNA and muropeptides
    不详
    IMMUNOBIOLOGY, 2005, 210 (6-8) : 586 - 586
  • [38] Baseless assumptions: Activation of TLR9 by DNA
    Gangloff, Monique
    Gay, Nicholas J.
    IMMUNITY, 2008, 28 (03) : 293 - 294
  • [39] CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA
    Yasuda, K
    Rutz, M
    Schlatter, B
    Metzger, J
    Luppa, PB
    Schmitz, F
    Haas, T
    Heit, A
    Bauer, S
    Wagner, H
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (02) : 431 - 436
  • [40] TLR9 agonistic CPG-oligodeoxynucleotides and IL-15 stimulate activation, proliferation, and differentiation of bone marrow B lymphocytes from rheumatoid arthritis patients
    Rudnicka, W.
    Warnawin, E.
    Zanova, E.
    Kontny, E.
    Maslinski, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A30 - A30
12345